• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性非恶性疼痛对高速公路驾驶性能的影响。

Effect of chronic nonmalignant pain on highway driving performance.

作者信息

Veldhuijzen D S, van Wijck A J M, Wille F, Verster J C, Kenemans J L, Kalkman C J, Olivier B, Volkerts E R

机构信息

Utrecht Institute for Pharmaceutical Sciences, Rudolf Magnus Institute of Neuroscience, Department of Psychopharmacology, University of Utrecht, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands.

出版信息

Pain. 2006 May;122(1-2):28-35. doi: 10.1016/j.pain.2005.12.019. Epub 2006 Feb 21.

DOI:10.1016/j.pain.2005.12.019
PMID:16495013
Abstract

Most pain patients are treated in an outpatient setting and are engaged in daily activities including driving. Since several studies showed that cognitive functioning may be impaired in chronic nonmalignant pain, the question arises whether or not chronic nonmalignant pain affects driving performance. Therefore, the objective of the present study was to determine the effects of chronic nonmalignant pain on actual highway driving performance during normal traffic. Fourteen patients with chronic nonmalignant pain and 14 healthy controls, matched on age, educational level, and driving experience, participated in the study. Participants performed a standardized on-the-road driving test during normal traffic, on a primary highway. The primary parameter of the driving test is the Standard Deviation of Lateral Position (SDLP). In addition, driving-related skills (tracking, divided attention, and memory) were examined in the laboratory. Subjective assessments, such as pain intensity, and subjective driving quality, were rated on visual analogue scales. The results demonstrated that a subset of chronic nonmalignant pain patients had SDLPs that were higher than the matched healthy controls, indicating worse highway driving performance. Overall, there was a statistically significant difference in highway driving performance between the groups. Further, chronic nonmalignant pain patients rated their subjective driving quality to be normal, although their ratings were significantly lower than those of the healthy controls. No significant effects were found on the laboratory tests.

摘要

大多数疼痛患者在门诊接受治疗,并参与包括驾驶在内的日常活动。由于多项研究表明慢性非恶性疼痛可能会损害认知功能,因此出现了慢性非恶性疼痛是否会影响驾驶表现的问题。因此,本研究的目的是确定慢性非恶性疼痛对正常交通情况下实际高速公路驾驶表现的影响。14名患有慢性非恶性疼痛的患者和14名年龄、教育水平和驾驶经验相匹配的健康对照者参与了该研究。参与者在正常交通情况下于一条主要高速公路上进行了标准化的道路驾驶测试。驾驶测试的主要参数是横向位置标准差(SDLP)。此外,在实验室中对与驾驶相关的技能(跟踪、分散注意力和记忆)进行了检查。通过视觉模拟量表对疼痛强度和主观驾驶质量等主观评估进行评分。结果表明,一部分慢性非恶性疼痛患者的SDLP高于相匹配的健康对照者,这表明其高速公路驾驶表现较差。总体而言,两组之间在高速公路驾驶表现上存在统计学上的显著差异。此外,慢性非恶性疼痛患者将其主观驾驶质量评为正常,尽管他们的评分明显低于健康对照者。在实验室测试中未发现显著影响。

相似文献

1
Effect of chronic nonmalignant pain on highway driving performance.慢性非恶性疼痛对高速公路驾驶性能的影响。
Pain. 2006 May;122(1-2):28-35. doi: 10.1016/j.pain.2005.12.019. Epub 2006 Feb 21.
2
Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients.25毫克阿米替林对慢性神经性疼痛患者实际驾驶的急性和亚慢性影响。
J Psychopharmacol. 2006 Nov;20(6):782-8. doi: 10.1177/0269881106061101. Epub 2006 Jan 9.
3
Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.抗抑郁药与驾驶能力受损:来自标准道路测试的实证证据。
J Clin Psychiatry. 2003 Jan;64(1):20-9.
4
Chronic pain and driving: proceed with caution.慢性疼痛与驾驶:谨慎行事。
Pain. 2006 May;122(1-2):6-7. doi: 10.1016/j.pain.2006.01.036. Epub 2006 Mar 13.
5
[Driving fitness/driving capacity of patients treated with methadone].[接受美沙酮治疗患者的驾驶适宜性/驾驶能力]
Schweiz Med Wochenschr. 1998 Oct 10;128(41):1538-47.
6
Driver distraction: the effects of concurrent in-vehicle tasks, road environment complexity and age on driving performance.驾驶员注意力分散:车内并行任务、道路环境复杂性和年龄对驾驶性能的影响。
Accid Anal Prev. 2006 Jan;38(1):185-91. doi: 10.1016/j.aap.2005.09.007. Epub 2005 Oct 12.
7
Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood.一种阿片类药物(羟考酮/对乙酰氨基酚)和一种非甾体抗炎药(溴芬酸)对驾驶能力、记忆功能、精神运动表现、瞳孔大小及情绪的影响。
Clin J Pain. 2006 Jun;22(5):499-504. doi: 10.1097/01.ajp.0000202981.28915.b2.
8
A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic.卡马西平与N-甲基-D-天冬氨酸(NMDA)受体拮抗剂瑞玛西胺对实际交通中道路跟踪及跟车性能影响的对比研究。
Psychopharmacology (Berl). 2002 Jan;159(2):203-10. doi: 10.1007/s002130100898. Epub 2001 Sep 22.
9
Driver fatigue and highway driving: a simulator study.驾驶员疲劳与高速公路驾驶:一项模拟器研究。
Physiol Behav. 2008 Jun 9;94(3):448-53. doi: 10.1016/j.physbeh.2008.02.015. Epub 2008 Mar 2.
10
Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.评估慢性非癌性疼痛患者长期接受透皮丁丙诺啡治疗时的认知和精神运动表现。
Anesth Analg. 2007 Nov;105(5):1442-8, table of contents. doi: 10.1213/01.ane.0000281078.65585.1e.

引用本文的文献

1
The effects of orally ingested Delta-9-Tetrahydrocannabinol on drivers' hazard perception and risk-taking behaviours: A within-subjects study of medicinal cannabis users.口服Δ-9-四氢大麻酚对驾驶员危险感知和冒险行为的影响:对药用大麻使用者的一项自身对照研究。
Psychopharmacology (Berl). 2025 Jul 31. doi: 10.1007/s00213-025-06869-w.
2
The driving-related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation.澳大利亚首都地区大麻合法化后大麻使用者与驾驶相关的态度、信念和行为。
Drug Alcohol Rev. 2025 Feb;44(2):588-601. doi: 10.1111/dar.13983. Epub 2025 Jan 7.
3
Investigating self-report and neuropsychological assessments of cognitive flexibility in people with and without persistent pain: An online, cross-sectional, observational study.
对有持续性疼痛和无持续性疼痛人群的认知灵活性进行自我报告和神经心理学评估:一项在线横断面观察性研究。
Br J Pain. 2024 Apr;18(2):176-196. doi: 10.1177/20494637231215260. Epub 2023 Nov 21.
4
A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performance.一项半自然主义、开放性标签研究,旨在考察规定医疗大麻使用对模拟驾驶表现的影响。
J Psychopharmacol. 2024 Mar;38(3):247-257. doi: 10.1177/02698811241229524. Epub 2024 Feb 8.
5
Understanding the Experience and Impacts of Brain Fog in Chronic Pain: A Scoping Review.了解慢性疼痛中脑雾的体验与影响:一项范围综述
Can J Pain. 2023 Jul 10;7(1):2217865. doi: 10.1080/24740527.2023.2217865. eCollection 2023.
6
Aches and Pains: How Do They Affect Transitions From Driving?疼痛:它们如何影响驾驶转换?
Innov Aging. 2022 Dec 14;7(1):igac074. doi: 10.1093/geroni/igac074. eCollection 2023.
7
[Cognition and driving ability in chronic pain syndrome].[慢性疼痛综合征中的认知与驾驶能力]
Nervenarzt. 2023 Apr;94(4):335-343. doi: 10.1007/s00115-022-01387-y. Epub 2022 Sep 28.
8
Association between prescribed opioid dose and risk of motor vehicle crashes.处方阿片类药物剂量与机动车事故风险的关联。
Pain. 2023 Apr 1;164(4):e228-e236. doi: 10.1097/j.pain.0000000000002790. Epub 2022 Sep 26.
9
New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada.新阿片类药物使用与加拿大安大略省机动车碰撞相关的急诊就诊风险。
JAMA Netw Open. 2021 Nov 1;4(11):e2134248. doi: 10.1001/jamanetworkopen.2021.34248.
10
Age-Related Diseases and Driving Safety.年龄相关性疾病与驾驶安全
Geriatrics (Basel). 2020 Oct 19;5(4):80. doi: 10.3390/geriatrics5040080.